Revonto Alternatives Compared
Revonto (dantrolene) | Dantrolene | Dantrium (dantrolene) |
|
---|
Revonto (dantrolene) | Dantrolene | Dantrium (dantrolene) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Chronic Spasticity, Malignant Hyperthermia. Revonto may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Spasticity, Malignant Hyperthermia. Dantrolene may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Spasticity, Malignant Hyperthermia. Dantrium may also be used for purposes not listed in this medication guide. |
Related suggestions Chronic Spasticity
Malignant Hyperthermia
|
|||||||||||||||
More about Revonto (dantrolene) | More about Dantrolene | More about Dantrium (dantrolene) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Dantrolene has an average rating of 7.5 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 25% reported a negative effect. |
Dantrium has an average rating of 6.7 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Revonto side effects |
View all Dantrolene side effects |
View all Dantrium side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic approved |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Revonto prices |
View all Dantrolene prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other dantrolene brands include: Dantrium, Dantrium Intravenous, Ryanodex | Dantrium, Dantrium Intravenous, Revonto, Ryanodex | Other dantrolene brands include: Dantrium Intravenous, Revonto, Ryanodex | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
8.7 hours |
8.7 hours |
8.7 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 305 drugs are known to interact with Revonto:
|
A total of 305 drugs are known to interact with Dantrolene:
|
A total of 305 drugs are known to interact with Dantrium:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
July 24, 2007 |
January 15, 1974 |
January 15, 1974 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.